Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Biolase Receives Eye Treatment Patent

Photonics.com
Sep 2011
IRVINE, Calif., Sept. 12, 2011 — Dental laser manufacturer Biolase Technology Inc. has received US Patent No. 7,997,279, titled “Methods for Treating Eye Conditions,” from the US Patent and Trademark Office, the company announced recently.

The new patent is the 13th issued in the ophthalmic family, with 20 others pending. It continues and expands US Patent No. 7,665,467, with broad claims covering the use of laser technology for treating various conditions of the eye, including presbyopia — the inability to focus sharply for near vision — and it opens up opportunities in oculoplastics as well as the treatment of cataracts and glaucoma.

In other news, the company has formed a Oculase Inc., a wholly owned subsidiary based in Delaware. The new entity will own and develop the company’s ophthalmic assets and technologies. Biolase said it plans to develop an operating unit at the new venture to focus specifically on diseases and conditions of the eye.

For more information, visit: www.biolase.com  



GLOSSARY
ophthalmology
The branch of medicine involved in the study of the anatomy, functions, diseases and treatments of the eye.
presbyopia
A state in which the human eye has very little or no power of accommodation. A common and normal condition in the eyes of those age 50 and older.
Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.